Ten Bridge Communications @TenBridge
We guide biotech through the big moments. tenbridgecommunications.com Boston, MA Joined February 2017-
Tweets3K
-
Followers928
-
Following902
-
Likes96
We have the privilege of partnering with clients on the leading edge of science, from leaders in gene editing to tRNA therapeutics, chemoproteomics and beyond. As a core strategic partner to those setting the pace in biotech, we help build bridges that can speed the translation…
Wonderful news for #TBCPartner @PureTechH on the successful launch of @SeaportTx! Backed by a $100 million Series A financing round with support from top biotech investors including ARCH Venture Partners, @SofinnovaVC and @ThirdRockV, Seaport is rapidly advancing a clinical-stage…
Wonderful news for #TBCPartner @PureTechH on the successful launch of @SeaportTx! Backed by a $100 million Series A financing round with support from top biotech investors including ARCH Venture Partners, @SofinnovaVC and @ThirdRockV, Seaport is rapidly advancing a clinical-stage…
Did you know that @hootsuite recommends videos of 30 and 44 seconds for LinkedIn and X, respectively? On the one hand, it can be difficult to boil down all you want to say in to such a short amount of time. On the other, users’ attention on these channels is precious and…
Congratulations to #TBCPartner @intelliatx who made news by dosing a patient in the first Phase 3 clinical trial of an in vivo CRISPR therapy. Read this recent article from @WSJ by Betsy McKay to learn why “in vivo is the future.” wsj.com/health/pharma/…
Some exciting news for #TBCPartner Capstan Therapeutics who this week announced an oversubscribed Series B round of $175 million. Kyle LaHucik (@ky_lahucik) spoke with Capstan President & CEO Laura Shawver, Ph.D., on what’s next for the team and what we hope to expect from its in…
#TBCPartner Clasp Therapeutics launched today with an impressive $150 million Series A that they will use to progress their innovative T cell engager platform to the clinic. As they work to develop novel medicines that can target tumor cells with absolute specificity, they are a…
#TBCPartner Clasp Therapeutics launched today with an impressive $150 million Series A that they will use to progress their innovative T cell engager platform to the clinic. As they work to develop novel medicines that can target tumor cells with absolute specificity, they are a…
Last week, nearly the entire Ten Bridge team gathered in our Boston headquarters for a week of collaborating in-person. We also took it as an opportunity to get together outside the office for some rock climbing and bowling. We love getting to have these moments to connect as a…
What do digital strategies and clinical trial design have in common? They both leverage data to measure success. Traditionally, digital marketing focuses on generating revenue. But with an early-stage biotech, you may be many years away from having an approved product. So how…
Exciting update from #TBCPartner @C4Therapeutics, Inc., announcing its second discovery deal in a matter of months. Congrats, team!
Exciting update from #TBCPartner @C4Therapeutics, Inc., announcing its second discovery deal in a matter of months. Congrats, team!
Proud to support #TBCPartner Orbis Medicines in its launch this week! With an incredible team and €26M in seed financing from @novoholdings & @ForbionLifeSci, Orbis is poised to be a leader in oral macrocycle drug development.
Proud to support #TBCPartner Orbis Medicines in its launch this week! With an incredible team and €26M in seed financing from @novoholdings & @ForbionLifeSci, Orbis is poised to be a leader in oral macrocycle drug development.
Congratulations to #TBCPartner FogPharma on the successful closing of a $145 million Series E financing with the strong backing of multiple blue chip life sciences investors. As FogPharma CEO Mathai Mammen (@mmammen) told @ADeAngelis_bio of @statnews: "Life is short. Let's try,…
Congratulations to #TBCPartner FogPharma on the successful closing of a $145 million Series E financing with the strong backing of multiple blue chip life sciences investors. As FogPharma CEO Mathai Mammen (@mmammen) told @ADeAngelis_bio of @statnews: "Life is short. Let's try,…
Drug development is a slow process. Particularly for those brave enough to create a new modality or platform, it can take quite a while to advance a program into the clinic. So if you recently launched, how do you keep investors, job seekers and the biotech community at large…
The FDA recently added black boxes to the labels of approved CAR T therapies, warning of secondary cancer risks. This prompted BioCentury to survey how next-gen approaches could avoid this safety hurdle moving forward. The topic is becoming increasingly relevant as many…
The FDA recently added black boxes to the labels of approved CAR T therapies, warning of secondary cancer risks. This prompted BioCentury to survey how next-gen approaches could avoid this safety hurdle moving forward. The topic is becoming increasingly relevant as many…
Do you know the difference between an endpoint and an outcome? Are there times when one is more appropriate than the other in a sentence? Drawn from TBC’s internal series on biotech vocabulary called “Words Have Meaning,” Matt Crenson breaks down these commonly used but perhaps…
Congratulations to #TBCPartner @intelliatx on a second publication in The New England Journal of Medicine – this time for its NTLA-2002 Phase 1 data for patients with hereditary angioedema. Great work, team!
Congratulations to #TBCPartner @intelliatx on a second publication in The New England Journal of Medicine – this time for its NTLA-2002 Phase 1 data for patients with hereditary angioedema. Great work, team!
The first quarter of the year always tends to see a flurry Series A funding announcements. With so much attention focused on what you’ll say in your launch press release, what programs you’ll disclose on the website, and how you’ll explain your science to a broader audience for…
ICYMI: #TBCPartner Myrobalan Therapeutics launched this month with $24 million to develop orally available small molecule neurorestorative therapies to reverse key brain pathologies and repair and restore neural function in high-unmet need CNS conditions. Check out this recent…
With #JPM24 now in the rear view, we’re recapping some of the exciting updates from our #TBCPartners to kick off the new year. We're looking forward to what 2024 has in store for our partners and the biotech community as a whole.
Ahead of its #JPM24 presentation later today, #TBCPartner @MolecularPrtnrs announced a co-development agreement to develop novel Radio-DARPin therapeutics (RDT) for multiple oncology targets, including Delta-like ligand 3 (DLL3). We look forward to tuning in to the team’s…
Ahead of its #JPM24 presentation later today, #TBCPartner @MolecularPrtnrs announced a co-development agreement to develop novel Radio-DARPin therapeutics (RDT) for multiple oncology targets, including Delta-like ligand 3 (DLL3). We look forward to tuning in to the team’s…
We're looking forward to seeing all our #TBCPartners' hard work over the last year come to fruition at #JPM24. This is always an exciting time for the industry, and we can't wait to see what's in store. Be sure to be on the lookout for the following presentations if you are there…
Bruce Booth @LifeSciVC
50K Followers 731 Following Early stage biotech VC. Recovering scientist. Opinions expressed are solely my own and do not express the views or opinions of Atlas Venture.
Allison DeAngelis @ADeAngelis_bio
5K Followers 891 Following Reporter covering biopharma startups and venture capital at @statnews. Formerly @thisisinsider and @bosbizjournal.
Johannes Fruehauf🇺.. @JFruehauf
4K Followers 2K Following Life Science Entrepreneur, Startup Enthusiast. Founder LabCentral/Biolabs: Cambridge,BOS,NYC,NC,SD,Princeton,Philly, LA,DFW,Heidelberg, VC@MissionBioCapital
Abbas Kazimi @AbbasRKazimi
406 Followers 326 Following Chief Business Officer @NimbusTx. Biotech transactor & drug discovery enabler in the hope of getting patients better medicines. Tweets are solely my own views.
Kendalle Burlin O'Con.. @KendalleOC
732 Followers 909 Following President & Chief Executive Officer @MassBio, Speaker, Lawyer, @BosBizJournal 40 Under 40, Board Member @ACSNewEngland & @massbioed, Co-Chair ACS ResearcHERS™
Dyne Therapeutics @Dyne_tx
1K Followers 323 Following Advancing life-transforming therapies for serious muscle diseases. Community guidelines: https://t.co/0XslT2HWqg
Bob Coughlin @BobCoughlin
7K Followers 2K Following Managing Director, Life Sciences @JLL, former @MassBio CEO. Public Speaker, Former MA House of Representatives, Patient Advocate, CF Dad, #PatientDriven
FSHD Society @FSHDSociety
2K Followers 785 Following World’s largest research-focused patient organization for facioscapulohumeral muscular dystrophy (FSHD). Empowering patients, accelerating therapies. #CureFSHD
Stephanie Simon @StephanieSimon_
7K Followers 2K Following Dean for Communications and Strategic Initiatives @HarvardChanSPH. Former managing director @tenbridge, managing editor @statnews & national reporter @ LAT, WSJ
Jason Rhodes @JasonPaulRhodes
2K Followers 2K Following 🇺🇸 🇮🇱✡️ 🇨🇾Roma, FCB, biotech, some other stuff.
Gifford @JiveJade12510
1 Followers 264 Following
Thooshesh @thooshesh8032
1 Followers 92 Following
Natalie_Adam @AdamNatali94218
10 Followers 957 Following
Shismoez @Shismoez144869
1 Followers 361 Following
parneet_59 @59Parneet73879
0 Followers 906 Following
ANNA @sehrawat9624820
3 Followers 869 Following
Ar_nav513 @ArNav51342856
6 Followers 829 Following
Dyno Therapeutics, In.. @Dyno_Tx
2K Followers 49 Following Dyno Therapeutics is a pioneer in applying artificial intelligence to gene therapy, focused on AAV capsid engineering. Join our startup: https://t.co/HwkUQK9o0a
K. Zissou @KM_Zissou
60 Followers 429 Following
pavlovlaUk @PavlovlaUk
1K Followers 5K Following You like to smell good to shine brightly. Come discover your favorite perfume and many other cosmetic products .
Lisa Sanders @LisaSander41437
91 Followers 3K Following
Genevieve @Genevieve470997
19 Followers 2K Following
Alex Lash @alexlash
6K Followers 655 Following Editor @TheFrisc: independent nonprofit news/analysis for an ever-changing San Francisco (my hometown). Past writing lives include biotech, baseball, and tech.
Dereon Chan @DereonChan27143
85 Followers 3K Following
Lydia Gunn @LydiaGunn36062
91 Followers 1K Following 🌿 Wellness Enthusiast | Nourishing Mind, Body & Soul 💚 | Your daily dose of holistic health tips🏋️♀️ | Let's embark on a journey to a healthier YOU 🌱
Krystal Braxton @BraxtonKry70405
54 Followers 1K Following Passionate about health and wellness 💪 | Dedicated to promoting a balanced lifestyle 🌱 | Join me on the journey to a healthier, happier life! 🌟
LabRadar 🇮🇱 �.. @LabbRadar
821 Followers 839 Following Nice Jewish boy w/ biotech focus. Confronting anti-semitism & engaging in dialogue. Not financial advice, but a scholarly expedition! Current focus: $NVCT
Joy Pullela @pullela_joy
187 Followers 2K Following
Nicole Foy @foynicole
961 Followers 4K Following Texas Biomed communicator. San Antonian. Former/forever journalist. Raising 3 fierce feminist daughters. Opinions are my own.
Sahaba Sultana @Sahabadigital
626 Followers 4K Following ||PROMOTE YOUR BUSINESS TO THE NEXT LEVEL|| |👉ProfessionalDigital Marketer & Business Growth expert🎯| ||Visit Portfolio : https://t.co/8NHGHggfjw
Chandler Ruehrwein @openbiotechjobs
7K Followers 7K Following Human Resources-connect job seekers 2 Biotech/Pharma-MA, NJ, NY, PA, CT, RI #Veterans #biotech #pharma #jobs
USNewsper @USNewsper
2K Followers 5K Following 📰 Your Daily Source for All Things happening in America | Stay Informed with USNewsper! 🌐 | Breaking News, Trends, & Analysis 🚀 |
Krishnan Viswanadhan @viswanak
147 Followers 524 Following President and COO at Be Bio. Humbled to be part of biotech innovation.
Teresa Carr @TeresaRCarr
988 Followers 2K Following Science and health journalist; Senior Contributor @Undark; @KSJatMIT '18; bylines: @ConsumerReports, @NYTParenting, @GuardianUS, & more. I ❤️ poodles and tacos
DC Maryland Virginia .. @DCBionetwork
963 Followers 5K Following Life science news and jobs from Washington DC, Maryland and Virginia. Part of @BiotechNetworks, connecting #biotech since 2008.
Bobo @shuiboto
0 Followers 164 Following
Christina Lilliehook @kikiluring
7 Followers 11 Following
BIOS @bios_community
15K Followers 2K Following Uniting the Life Science Ecosystem In #PatientImpact — Highlighting Industry Leaders Shaping The Future Of Medicine✨By: @alixventures
quiet_bull @quiet_bull14
29 Followers 54 Following
Verona Pharma @VeronaPharma
619 Followers 455 Following Developing life enhancing treatments for chronic respiratory diseases
Chris Fisher, Ph.D. @C_J_Fisher
221 Followers 632 Following Ph.D. #ChemicalBiologist & #ScientificCommunicator driven to advocate for #ScienceInSociety. Views expressed are my own. He/him.
ModeX Therapeutics @ModeXTx
119 Followers 122 Following We are shaping a new and better way to make transformational medicines a reality for people in need. ModeX is an OPKO Health company (Nasdaq: OPK).
Stella Lempidaki @lymphidaki
214 Followers 1K Following Scientist | Strategic Healthcare Communications. Pop culture and independent film lover.
Douglas Eby @DCEifyouplease
290 Followers 1K Following Founder & CEO Cambridge Science, Co-Founder Vivtex, Ovibio, Kyttaro - Senior Fellow Harvard Law School
Ry Leahy @RySciComms
706 Followers 3K Following Science Communications for Advanced Therapies - Cell & Gene Therapy - Vice President of Research @phacilitate / #cellltherapy #genetherapy #firstgenacademic
Akeso Inc. @AkesoInc
67 Followers 210 Following We are dedicated to the research, development, manufacturing and commercialization of novel antibody drugs that are affordable to patients worldwide. #9926.HK
Chelsea Rule @ChelseaRule7
12 Followers 124 Following Life Science and Healthcare Communication and Consulting @macdougallbio | Microbiology & Immunology Ph.D.
Jeff alene Porter @alene_jeff
175 Followers 914 Following
Matt Prekupec @MattPrekupec
418 Followers 4K Following Nocturnist @DeptVetAffairs. MPH candidate @JohnsHopkinsSPH. Early-stage life sciences and deep tech investing. Mbr @GaingelsVC.
Márton Mészáros @mesmarton
38 Followers 210 Following starting sth new in longevity. used to run ops and alzheimer's studies at https://t.co/zzvZpvrmgP.
Christine Yu @mengchong818
0 Followers 30 Following Licengsing in/out of innovative drugs @Qilu pharmaceutical
Pat Licata @patlicata
3K Followers 6K Following Pat Licata & Assoc. National Medical Executive Search Firm Proud Republican TRUMP 2024 Views are My Own If You Are For America First Follow!
Heather D. Marshall, .. @CloudyMediaBlog
1K Followers 2K Following Public Health Content Manager @DynaMedex by day, science blogger by night. Immunology and infectious diseases are my jam. Opinions are my own.
Ian Heller @Ian_S_Heller
134 Followers 332 Following Biologist 🐟🧬🦴🦨🦇 | PhD @DevBioStanford | Philadelphia | he/him
Lauren Valentine Elle.. @Valentine_Eller
145 Followers 1K Following Devoted Mom. Biotech strategist. Patient-centric, people-focused. Drive healthcare advances, access, & outcomes - to enhance lives. Opinions my own.
Adam Feuerstein ✡�.. @adamfeuerstein
114K Followers 748 Following Reporter @statnews. The Harry Kane of biotech. Dog ❤️er. Polk Award winner. #COYS. Said one analyst: The likes of Adam Feuerstein attack viciously.
Brad Loncar @bradloncar
69K Followers 365 Following #Biotech, Founder of @BiotechTVHQ, KC native, @univmiami hurricane.🧬🙌
Bruce Booth @LifeSciVC
50K Followers 731 Following Early stage biotech VC. Recovering scientist. Opinions expressed are solely my own and do not express the views or opinions of Atlas Venture.
Daphne Zohar @daphnezohar
22K Followers 886 Following Founder & CEO of @SeaportTX. Founding CEO @PureTechH. I share mostly biotech news & commentary. Co founder/host @BiotechCH. Board of @IamBiotech
Luke Timmerman @ldtimmerman
34K Followers 231 Following Biotech Journalist. Founder @TimmermanReport. Mountaineer. Volunteer. @LS_Cares @DamonRunyon
Jeb Keiper @JebKeiper
4K Followers 418 Following CEO @NimbusTx. A guy (he/him) helping teams discover and develop new medicines for patients. Any tweets are solely my own personal views.
David R. Liu @davidrliu
64K Followers 59 Following Professor at Harvard, Broad Institute, & HHMI. Our lab integrates chemistry & evolution to illuminate biology & enable new therapeutics. IG/Threads: @davidrliu1
Matthew Herper @matthewherper
111K Followers 3K Following Writing and events at STAT. This is biology's century; Every data point has a face. ‘21 Polk Award. Mastodon: @[email protected]
Jay Bradner, M.D. @jaybradner
21K Followers 933 Following Physician-scientist making medicines with friends, memories with family. EVP R&D and CSO at Amgen
Manisha Pai @mppai
1K Followers 693 Following Biotech investor relations. Voracious reader, eater & wine drinker. Ex-pat Mainer. Helicopter mom to a senior rescue dog. Tweets & opinions are my own. she/her
Nimbus Therapeutics @NimbusTx
2K Followers 121 Following We integrate computational chemistry and other advanced technologies to design breakthrough medicines and transform drug development. https://t.co/gANxj1Ufzq
Charlie Baker @MAGovArchive
329K Followers 688 Following Official account of Governor Charlie Baker of Massachusetts.
Michael Gilman @michael_gilman
24K Followers 784 Following Scientist, entrepreneur, ex-biopharm exec, former FM radio jock, lifelong hockey fan, aspiring guitar player, #immigrant. CEO @ArrakisTx. Just @gilman on...
Allison DeAngelis @ADeAngelis_bio
5K Followers 891 Following Reporter covering biopharma startups and venture capital at @statnews. Formerly @thisisinsider and @bosbizjournal.
Kyle LaHucik @ky_lahucik
3K Followers 2K Following covering the VC $, people, deals + biotechs behind new meds @Endpts | [email protected] | askin Qs, joggin 26.2 | 🗞 📷 🌎 | XC + Track coach | 🏳️🌈
Ryan Cross the Scienc.. @RLCscienceboss
4K Followers 839 Following Senior Science Correspondent for @Endpts covering biotech, drug discovery, gene editing, RNA, and more. Formerly at Boston Globe and C&EN. Threads: ryancross
Samarth Kulkarni @CrisprSam
4K Followers 225 Following CEO and Chairman at CRISPR Therapeutics @CRISPRTX, which is pioneering a new era of gene-based medicines. Tweets are my own.
Johannes Fruehauf🇺.. @JFruehauf
4K Followers 2K Following Life Science Entrepreneur, Startup Enthusiast. Founder LabCentral/Biolabs: Cambridge,BOS,NYC,NC,SD,Princeton,Philly, LA,DFW,Heidelberg, VC@MissionBioCapital
Alex Harding @AlexHarding7
3K Followers 128 Following An internist in biotech | CRISPR Therapeutics | MGH Medicine
Verona Pharma @VeronaPharma
619 Followers 455 Following Developing life enhancing treatments for chronic respiratory diseases
SOTIO @SOTIO
1K Followers 164 Following A biotechnology company shaping the future of cancer #immunotherapies by translating compelling science into patient benefit. Member of @PPFGroup
Ribometrix @Ribometrix
363 Followers 13 Following Ribometrix is a biotechnology company developing small molecule therapeutics that modulate RNA biology to treat human diseases.
NEIDL @neidl
1K Followers 62 Following National Emerging Infectious Diseases Laboratories. Finding Cures. Saving Lives.
Epic Bio @EpicBiotech
254 Followers 22 Following Epic Bio is a biotechnology company developing ultra-compact therapies to modulate gene expression in vivo using the smallest known Cas protein
Dyno Therapeutics, In.. @Dyno_Tx
2K Followers 49 Following Dyno Therapeutics is a pioneer in applying artificial intelligence to gene therapy, focused on AAV capsid engineering. Join our startup: https://t.co/HwkUQK9o0a
Cerapedics @CerapedicsInc
118 Followers 42 Following Cerapedics is an Orthopedics company aspiring to redefine the standard of care for bone repair.
Ambagon Therapeutics @ambagontx
150 Followers 14 Following Expanding the druggable proteome to drug intrinsically disordered proteins.
Acepodia @AcepodiaInc
168 Followers 261 Following Acepodia is developing innovative and highly effective cell therapies for cancer that are broadly accessible for patients.
ModeX Therapeutics @ModeXTx
119 Followers 122 Following We are shaping a new and better way to make transformational medicines a reality for people in need. ModeX is an OPKO Health company (Nasdaq: OPK).
NORD @RareDiseases
41K Followers 3K Following National Organization for Rare Disorders (#NORD) is the voice of the #RareDisease community. Official US sponsor of #RareDiseaseDay.
Rare Action Network @RareAction
3K Followers 301 Following Advocating at the state & federal level to improve the lives of the 30 million Americans with #RareDiseases. #RareAction: a #NORD (@RareDiseases) initiative.
Adam Gridley @AdamDGridley
132 Followers 535 Following CEO @AllayTx | Biotech, STEM & Skiing Interests & Tweets are my own
Vor Bio @VorBio
648 Followers 289 Following Vor Bio's vision is to cure blood cancers through cell and genome engineering.
Ram Aiyar @ramaiyar
351 Followers 544 Following Biotechnology and Personalized Medicine aficionado investor turned entrepreneur
Rebecca Velez Frey �.. @rebecca_vfrey
163 Followers 354 Following CEO of Siduma Therapeutics. Mom to these ⬆️ amazing kids. Opinions my own. She/her.
Max Bayer @maxonwifi
2K Followers 2K Following staff writer @FierceBiotech covering new drug development | 📩 [email protected] or DM for Signal | past: @CBSNews | he/him
Cormac Sheridan @Cormac_Sheridan
2K Followers 5K Following Freelance science journalist. I write about what works in biotech - & what doesn't. Write for @NatureBiotech & one half of Smith & Sheridan on Biotech podcast
Sarepta Therapeutics @Sarepta
5K Followers 62 Following Commercial-stage biopharma company focused on the discovery & development of precision genetic medicine to treat rare neuromuscular diseases. https://t.co/HFP4txOCxe
Josh Madej @JoshMadej
1K Followers 489 Following Caregiver, patient, Cofounder @Carestry_ working to improve family caregiving through tech, personalization and automation @MITSloan @NorthwesternU alum
Eric Dai @EricDai_BioE
2K Followers 2K Following Investor at @_DimensionCap Biology x Technology | Tennessean, Chinese-American | Trust the Process
Jingyi Liu, MD, MBA @JingyiLiu8
551 Followers 635 Following IM Resident Physician @brighammedres | ex @Wharton @harvardmed @stanfordhealth | I tweet re: patient-first innovation + diversity in biopharma
Caroline H. Hopkins @Ch_Hops
1K Followers 3K Following Health journalist • Reporter @PrecOncNews • Contributor @NBCNews • Stories in @nytimes @voxdotcom @NatGeo • @ColumbiaJourn alum • [email protected]
Angus Rohan Chen @angRchen
3K Followers 2K Following undignified, unfunny, unaward-winning journalist doing health + cancer @STATNews. bylines: @wbur @npr @sciam @wnyc | English:Español:中文
Annalee Armstrong @AGKootenay
2K Followers 710 Following Ex-pat Canadian from B.C.'s East Kootenay. I like puppies & wine | Senior Editor for @FierceBiotech
Max Gelman @MaxGelman
2K Followers 493 Following Reporting on pharma and biotech, @endpts. Baseball fan, Northwestern alum. Email: [email protected]
Madeleine Armstrong @ByMadeleineA
7K Followers 1K Following Senior reporter at @ApexOnco; cat lover; Croydon Harrier
Dr Bethany Halford @beth_halford
3K Followers 1K Following Science writer (she/her) at @cenmag. Interested in molecules and molecule makers. Any opinions here are mine.
John Celebi @jcelebi
122 Followers 440 Following
Sara Nayeem @SaraNayeem
11K Followers 2K Following Invest in emerging biopharma co's as EVP, Investments at Enavate Sciences. Prior NEA and Avoro Ventures. I post advice for biopharma exec's and emerging VCs.
Denice Torres @DeniceMTorres
510 Followers 211 Following F100 exec turned entrepreneur, board member, + social change agent. Wildly passionate about big ideas, badass courage, being the change, underdogs rising up.
Sensei Bio @senseibio
283 Followers 185 Following Pushing the boundaries of science and imagination to discover and develop innovative medicines for patients.
ROME Therapeutics @rome_tx
383 Followers 94 Following We are developing novel therapies for cancer and autoimmune diseases by unlocking the role of the dark genome in human health and disease
Orca Bio @OrcaBio
1K Followers 232 Following Transforming allogeneic cell therapy for patients with blood cancer, genetic diseases, and autoimmune disorders
GenBio Inc @GenBioUSA
1K Followers 2K Following GenBio Inc is a pre-clinical USA based #biotech with a #dosage & #toxicology #IND program. #biotechnology https://t.co/sc0Sr4l8By https://t.co/MnQnfXGJ0K
C4 Therapeutics @C4Therapeutics
2K Followers 47 Following Transforming medicine with novel early stage therapies that eliminate disease-causing proteins #proteindegradation
Jaini @Jaini_Parekh25
11 Followers 39 Following
Julie Perlin @perlin_j
100 Followers 354 Following
IdleHandsCraftAles @idlehandsbeer
11K Followers 930 Following Brewery and Taproom located in Malden, MA T 3-9 W-Th 3-10 F-S 12-11 Su 12-7 Best of Boston 2020
Prilenia @PrileniaTx
2K Followers 244 Following Clinical stage biotech company focused on developing novel treatments for neurodegenerative and neurodevelopmental disorders
Fractyl Health @FractylHealth
797 Followers 515 Following Fractyl is a leader in advancing root-cause therapies for #type2diabetes. We’re pioneering dramatically different treatment approaches for metabolic disease.
Imvax, Inc. @imvax_inc
113 Followers 107 Following Imvax is a clinical-stage biotechnology company developing personalized, whole tumor-derived immunotherapies.
Nicole Oliverio @NicoleOliverio
15K Followers 2K Following Media Relations @danafarber | Disney Vacation Planner @mymickeyvaca | Former TV Broadcaster @boston25 & @7news | Mom of 2 | Catching up on 15yrs of missed sleep
Bill Alpert @blalpert
2K Followers 361 Following Bill Alpert is a Senior Writer at Barron’s, where since 1984 he has published nerdy feature stories, columns and investigative projects of use to investors.
So excited to share our story revealing structures, functions and adaptations of the human LINE-1 retrotransposon, an ancient genetic parasite that has written 1/3 of the human genome and is implicated in cancer, aging, & autoimmunity. Now out in @Nature nature.com/articles/s4158…
Company News: @BridgeBioPharma's Neil Kumar reviews #AHA23 data and the company's pipeline and finances. $BBIO Full video: biotechtv.com/post/bridgebio…
VERY early but promising signs from 2 studies testing CAR-T cell therapy in glioblastoma. Tumors shrank in days. "I’ve seen everything. And this is the best stuff I’ve seen in my career," UPenn’s Donald O’Rourke told me. Read more in my story for @endpts endpts.com/car-t-cell-the…
The 2nd Annual #darkgenomeSymposium is underway! ROME and co-hosts @Enara_Bio & @NucleomeTx are proud to convene these cross-disciplinary discussions on recent progress and new horizons in #darkgenome research.
Hot off the presses: @KapellerRosana and @dennis_zaller spoke recently with @NatRevDrugDisc about ROME’s novel approach to treating #autoimmunedisease by targeting the virus-like elements of the #darkgenome. Read the article 👇
Biotechs step on cGAS for autoimmune diseases bit.ly/3MyjpGA Read about the progress behind the entry of the first inhibitor of cGAS-STING into the clinic, as companies build the case for a range of novel anti-inflammatory drugs in autoimmune diseases, including lupus
Today is #NationalSTEMDay. A @Health_Affairs study shows biopharma innovation is responsible for 35% of the uptick in life expectancy in the U.S. from 1990-2015. Our team is proud to tackle serious diseases & work towards better patient care. bit.ly/44iXsCz
Biotech companies are turning to #mRNA as a new way to make off-the-shelf (and in vivo!) cell therapies for cancer and autoimmune disease. @leilei_wuu and I report for @endpts on mouse studies from @moderna_tx + @CarismaTher, @orna_tx, and @capstantx endpts.com/mrnas-next-tri…
Bright Minds: Y-Trap's CEO @rishibedi, an expert on predictive and generative AI, describes how they are changing drug development. #SITC23 Full video: biotechtv.com/post/y-trap-ri…
This week, we are attending #BIOEurope in Munich to meet with potential partners to build on synergies, leverage capabilities and create new opportunities for our #DARPin platform. We look forward to sharing the latest progress across our #oncology programs!
BREAKING: Today, we announced the @US_FDA approved our therapy to treat Duchenne muscular dystrophy, providing a new treatment option for this rare, degenerative disease. Learn more about this important milestone here: bit.ly/3JufCZg
Later this week, a team of biotech executives will land near the eastern coast of Africa with one singular goal: to summit Mt. Kilimanjaro, having raised more than $1 million for the Fred Hutchinson Cancer Center. bizjournals.com/boston/news/20…
We recently launched C4T’s DEI Council, a group of employees focused on fostering a culture in which every employee can be their best. We celebrated the Lunar New Year by sharing traditions across Asia. Our team wishes a safe and festive Lunar New Year to all who celebrate.
We recently recognized our colleagues for their outstanding contributions in 2022 and presented awards that recognized great leadership, citizenship and mentorship. Thank you to everyone for the impact made to advance our mission to deliver on the promise of #TPD.
We announced the first patient dosed in our Phase 1/2 clinical trial of CFT1946, an orally bioavailable BiDAC degrader, in BRAF V600 mutant solid tumors. More in today’s release: bit.ly/3wKaZDm #TPD
Nimbus CEO @JebKeiper joined @ldtimmerman’s Long Run podcast to share personal insights on the Nimbus story from our computational beginnings 14 years ago, through the Takeda acquisition of our allosteric TYK2 inhibitor, and what our next chapter holds. apple.co/3Hj4D3X
Excited to join an amazing team doing such important work!
Join us in welcoming @JoshMadej as he joins TBC as VP, digital and social engagement. Josh brings a passion for caregivers and patients, and over 15 years of experience in digital and social strategy, execution and analytics across the healthcare space.
Thank you, @TenBridge, for all of your hard work! We are so lucky to have partners like you to clear the current of invasive species. 💚🌱
We're excited to impact our communities via #TBCares, our new volunteer program. After a morning of river cleanup with the @charlesriver Watershed Association, we're looking forward to more social, health & environmental initiatives in the months to come! #InsideTBC
Thank you @TenBridge for putting together these outreach bags. These bags, along with your support, mean so much. Thank you for thinking of us!
Welcome, @ramaiyar to the LSC Boston Board of Advisors! Under Ram's leadership, @KorroBio has been an amazing partner in our #NetworkofGood. #LSCimpact
Trends for United States
You might like
